Back to
FIRST MANHATTAN CO. LLC.
VIVO
Showing 0 of 18 quarters
Position history for
FIRST MANHATTAN CO. LLC.'s holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, First Manhattan held 2,562 shares of VIVO (Meridian Bioscience), worth $85,084. First Manhattan's 13F filings listed VIVO from Q4 2018 to Q4 2022, 17 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.